A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome

Metabolic syndrome is a pathological condition characterized by obesity, hyperglycemia, hypertension, elevated levels of triglycerides and low levels of high-density lipoprotein cholesterol that increase cardiovascular disease risk and type 2 diabetes. Although numerous predisposing genetic risk fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Misselbeck, Karla, Parolo, Silvia, Lorenzini, Francesca, Savoca, Valeria, Leonardelli, Lorena, Bora, Pranami, Morine, Melissa J., Mione, Maria Caterina, Domenici, Enrico, Priami, Corrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861239/
https://www.ncbi.nlm.nih.gov/pubmed/31740673
http://dx.doi.org/10.1038/s41467-019-13208-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861239/
https://www.ncbi.nlm.nih.gov/pubmed/31740673
http://dx.doi.org/10.1038/s41467-019-13208-z

Ejemplares similares